.svg){kind=logo}
June 8, 2026
Adnexal Mass: What It Means, Types, and What Happens Next
An adnexal mass isn't a diagnosis: It's a descriptor for any growth near the ovaries or fallopian tubes. Learn what types exist, how doctors evaluate them.
You've had the blood work. The endoscopy came back clean. Your doctor says everything looks "normal." But your stomach still hurts after every meal, or you can't finish more than a few bites without feeling uncomfortably full.
If that sounds familiar, you're in the right place. A normal test result doesn't mean your symptoms are imaginary. Functional dyspepsia is a real clinical diagnosis, not a polite way of saying "we give up." The problem comes down to how your digestive system is (or in this case, isn't) working, not in any specific visible damage. Fortunately, with a diagnosis also comes a framework for handling it.
Functional dyspepsia (FD) is a chronic disorder of gut-brain interaction characterized by bothersome upper-GI symptoms — postprandial fullness, early satiation, epigastric pain, or epigastric burning — present for at least 3 months with onset at least 6 months prior, with no structural cause found on investigation (Rome IV criteria).
Rome IV is a set of globally-recognized diagnostic guidelines. The Rome IV definition of functional dyspepsia separates FD from conditions that look similar on the surface, but behave differently at their core. Differential considerations include
FD can overlap with all of these, and others. Yet despite being its own diagnosis, it is sometimes skipped or dismissed for being too non-specific. But this isn't a rare condition.
A 2024 systematic review and meta-analysis put global FD prevalence at around 8.4%. It's highest among women and in developing countries. And it's much more than inconvenient indigestion. A 2026 NEJM Clinical Practice review frames FD as "a serious syndrome capable of causing food aversion and significant weight loss."
The Rome IV symptom set for functional dyspepsia includes postprandial fullness (food sitting like a brick after a normal-sized meal), early satiation (feeling full after only a few bites), epigastric pain (between your navel and lower sternum), epigastric burning (heat or burning in the same zone), along with upper abdominal bloating, belching, and nausea. Not all symptoms need to appear simultaneously, and severity fluctuates over weeks and months. FD doesn't follow a linear course, which is a big part of why it's so frustrating to track.
The two functional dyspepsia subtypes provide a clinical map for treatment decisions:
Overlap between PDS and EPS is very common and is clinically important. Many patients don't fit neatly into one box. If your symptoms include both meal-triggered fullness and fasting epigastric pain, that's not unusual. But it does make treatment a bit more complicated.
That said, FD symptoms are not the same as alarm features, like vomiting blood, black stools, and unintentional weight loss. If you experience any of those, go straight to the doctor for urgent help.
There is no single physical cause of functional dyspepsia. Most patients have several overlapping contributors rather than one root mechanism. Think of it as a systems-level disruption, not a single broken part.
The main pathophysiological pathways include:
While the underlying cause it's easy (or often even necessary) to nail down, there are risk factors for functional dyspepsia which you can directly alter. If any of these apply to you, have a conversation about them with your clinician:
FD is diagnosed when Rome IV symptom criteria are met and investigation hasn't found a structural explanation. It's a diagnosis of positive pattern recognition plus exclusion. Again, this is not a catch-all for "we can't find anything wrong."
Diagnostic flowchart:
Common tests and when they're used:
🚩 Red flags — seek urgent evaluation:
Vomiting blood or coffee-ground material · Black or tarry stools · Unexplained or unintentional weight loss · Persistent vomiting preventing adequate food intake · New-onset symptoms in patients over 60 · Progressive difficulty swallowing · Chest, jaw, neck, or arm pain
FD treatments are real and evidence-based, but response for each individual treatment is far from guaranteed. So the path to resolution usually ends up being trial-and-error. If you find yourself going through a series of treatments that don't seem to be effective, take solace that this isn't a failure of care. Your doctor is (probably) doing the right thing. But FD is complex and doesn't have a single "gold standard cure." Finding the right treatment takes time.
Treatment should follow a clinical decision path guided by your subtype (EPS vs PDS). Your physician may point to a "NNT" value. This stands for "number needed to treat." Based on published studies, it indicates how many people with an illness need to undergo that specific treatment in order for one of them to have the illness resolve. So you can think of it a little bit like a fraction: An NNT of 5 means 1 in 5 people (or 20%) who get the therapy should expect to be "cured."
A 2023 network meta-analysis of 28 studies found that among prokinetic agents, metoclopramide was more effective than placebo and several comparable drugs, but cinitapride may carry fewer and less severe side effects. Every prescription has risks and trade-offs. If you're this deep into the details, this is a good conversation to have with your doctor and pharmacist.
Sometimes, experimentation doesn't just mean trying one treatment and then switching to another. Combination approaches are common. Either of two treatments on their own might not work for you, but both together may solve the problem. When you consider combinations, it starts to become clear how experimenting to find the right pathway can easily become a long and drawn-out process.
While subtypes and symptoms guide early prescriptions, switching or adding agents after 4–8 weeks of inadequate response is standard.
There is no universal diet for functional dyspepsia. No single food triggers FD in every patient. As you think about your food consumption, the goal is to identify your individual patterns through structured observation, not to follow a blanket elimination protocol.
Here are some practical, low-friction steps worth trying:
As you log your diet and symptoms, three to four weeks of consistent data is usually enough to start to find individual patterns. But full resolution often requires pattern recognition over many months. Even if you're documenting everything on paper, having a single place to archive your meal logs, symptom timing, medications, and test results reduces the memory burden that makes follow-up appointments less productive.
So consider putting your results in a single binder, or using a digital tool like myStoria to help consolidate all of your self-assessment and practitioner-provided data into a single health timeline. When you have repeated GI workups, complex symptom history, stacks of test results, and multiple medication trials consolidated in one place, it's much easier to understand your full medical picture, advocate for next steps, and avoid redundant testing. This is where organized health records (whether through an app like myStoria or a personal system) pay off across visits and across providers.
Do note that dietary and lifestyle changes will usually help to manage symptoms, but won't bring you to a full cure. That said, here's a simple 7-day symptom tracking template you can use:
A study published in Alimentary Pharmacology & Therapeutics estimated the U.S. economic cost of FD in 2009 at $18.4 billion. If you've experienced FD or any other complex medical condition, it's easy to sum up the tolls: Time away from work driven by repeated specialist visits, redundant diagnostic testing, lost productivity, and chronic medication use. In the study, FD patients reported an average of 3 visits to their primary care physician before ever seeing a specialist. 92% had an endoscopy procedure, 59% had an ultrasound, and 40% had a CT scan, with direct testing costs of $582 per patient.
Up to 340% of FD patients also meet the diagnostic criteria for IBS. Because FD symptoms overlap so much with IBS, GERD, gastroparesis, and peptic ulcer disease, many patients cycle through multiple rounds of testing before receiving a clear diagnosis. Each inconclusive result adds cost, delays treatment, and erodes confidence.
That said, there is cause for hope. One study found that the global pooled prevalence of FD has gradually decreased from 12.4% in 1990–2002 to 7.3% in 2013–2020. This may reflect better diagnostics, improved H. pylori eradication rates, dietary shifts, or greater access to treatment information. And while that trend is a huge improvement, it of course doesn't minimize the burden for the millions of people still currently affected.
Functional dyspepsia is common, clinically recognized, and treatable. But it requires patience, structured communication with your clinician, and realistic expectations about gradual improvement. A normal endoscopy isn't the end of the road. It's the beginning of a treatment plan built around your subtype, your triggers, and your response to therapy. You can get ahead of the next medical steps by tracking your symptoms consistently, bringing that data to your next appointment, and working with your provider to find the combination of strategies that not only makes you feel better over time, but helps you get back to normal.
Functional dyspepsia is a chronic disorder of gut-brain interaction that causes bothersome upper-GI symptoms, such as epigastric pain, burning, postprandial fullness, or early satiation, without a structural cause visible on testing. It is diagnosed using Rome IV criteria, which require symptoms for at least 3 months with onset at least 6 months earlier.
No. GERD involves acid reflux into the esophagus and is heartburn-predominant. IBS is a lower-GI disorder defined by changes in bowel habits (diarrhea, constipation, or both). FD centers on the upper abdomen. Overlap between these conditions is common, but they are separate diagnoses with distinct diagnostic criteria and treatment approaches.
Common tests include H. pylori breath or stool tests, upper endoscopy (EGD), blood work (CBC, metabolic panel), and gastric emptying studies when gastroparesis is suspected. Importantly, normal results on these tests support the FD diagnosis rather than ruling it out — they confirm there's no structural cause.
Triggers vary by person. Commonly reported ones include high-fat meals, coffee, alcohol, carbonated drinks, and spicy foods. Rather than blanket elimination, individual tracking over 3–4 weeks is the most effective way to identify your specific triggers and guide meaningful dietary changes.
Symptoms fluctuate, and some patients experience long periods of remission. However, for many people FD is a chronic condition that benefits from ongoing management, rather than resolving permanently on its own. A combination of dietary adjustments, medication, and sometimes psychological support can go a long ways.
